Healthy volunteers test new antifungal drug in Early-Stage trial
NCT ID NCT06961708
First seen Mar 20, 2026 · Last updated May 18, 2026 · Updated 11 times
Summary
This early-stage study looked at how the experimental drug fosmanogepix behaves in the bodies of 54 healthy Chinese adults. Participants received either a single dose or multiple doses of the drug, given by IV or as a pill, to measure safety and how the drug is processed. The goal was to gather basic information before testing it in people with fungal infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Xuhui Central Hospital, Longchuan North Road
Shanghai, 200237, China
Conditions
Explore the condition pages connected to this study.